Manulife (Manufacturers Life Insurance)
TMDX icon

Manulife (Manufacturers Life Insurance)’s Transmedics TMDX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51M Sell
15,234
-457
-3% -$59.6K ﹤0.01% 1612
2025
Q4 		$1.91M Sell
15,691
-669
-4% -$84K ﹤0.01% 1541
2025
Q3 		$1.84M Sell
16,360
-34
-0.2% -$3.98K ﹤0.01% 1554
2025
Q2 		$2.2M Sell
16,394
-1,202
-7% -$132K ﹤0.01% 1457
2025
Q1 		$1.18M Sell
17,596
-651
-4% -$44.8K ﹤0.01% 1738
2024
Q4 		$1.14M Sell
18,247
-226
-1% -$21K ﹤0.01% 1846
2024
Q3 		$2.9M Buy
18,473
+657
+4% +$101K ﹤0.01% 1419
2024
Q2 		$2.68M Buy
17,816
+870
+5% +$104K ﹤0.01% 1409
2024
Q1 		$1.25M Buy
16,946
+1,608
+10% +$133K ﹤0.01% 1726
2023
Q4 		$1.21M Sell
15,338
-227
-1% -$13.7K ﹤0.01% 1708
2023
Q3 		$852K Buy
15,565
+2,885
+23% +$208K ﹤0.01% 1819
2023
Q2 		$1.06M Buy
12,680
+516
+4% +$39.5K ﹤0.01% 1619
2023
Q1 		$921K Buy
12,164
+433
+4% +$29.9K ﹤0.01% 1680
2022
Q4 		$724K Buy
11,731
+1,182
+11% +$62.8K ﹤0.01% 1766
2022
Q3 		$440K Sell
10,549
-287
-3% -$12.5K ﹤0.01% 2059
2022
Q2 		$341K Sell
10,836
-200
-2% -$5.33K ﹤0.01% 2306
2022
Q1 		$297K Sell
11,036
-2,647
-19% -$47.4K ﹤0.01% 2519
2021
Q4 		$262 Sell
13,683
-169
-1% -$4.24K ﹤0.01% 2713
2021
Q3 		$458K Sell
13,852
-960
-6% -$29.3K ﹤0.01% 2349
2021
Q2 		$491K Buy
14,812
+568
+4% +$15.7K ﹤0.01% 2449
2021
Q1 		$591K Sell
14,244
-1,539
-10% -$47.4K ﹤0.01% 2182
2020
Q4 		$314K Buy
15,783
+1,945
+14% +$28.8K ﹤0.01% 2490
2020
Q3 		$191K Buy
13,838
+1,546
+13% +$26.5K ﹤0.01% 2589
2020
Q2 		$212K Buy
+12,292
New +$192K ﹤0.01% 2468

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TMDX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Transmedics (TMDX) stake by 2.9% in Q1 2026, selling an estimated $59.6K and leaving 15,234 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Manulife (Manufacturers Life Insurance) first reported a position in TMDX in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.9M in Q3 2024. 415 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 15,234 shares of Transmedics worth $1.51M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 457 Transmedics shares in Q1 2026, an estimated $59.6K.
  • Transmedics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1612 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Transmedics in Q2 2020 and has held it in 24 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Transmedics position peaked at $2.9M in Q3 2024.
  • 415 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.